CV
IBB icon

Counterweight Ventures’s iShares Biotechnology ETF IBB Stock Holding History

Counterweight Ventures’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,315
Closed -$1.18M – 80
2025
Q2 		$1.18M Buy
9,315
+272
+3% +$33.4K 0.77% 42
2025
Q1 		$1.16M Buy
9,043
+451
+5% +$61.2K 0.83% 43
2024
Q4 		$1.14M Buy
8,592
+138
+2% +$19.4K 0.8% 43
2024
Q3 		$1.23M Buy
8,454
+2,693
+47% +$390K 0.87% 41
2024
Q2 		$791K Buy
5,761
+245
+4% +$32.7K 0.6% 44
2024
Q1 		$757K Sell
5,516
-540
-9% -$73.7K 0.61% 44
2023
Q4 		$823K Buy
+6,056
New +$739K 0.75% 41

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Counterweight Ventures's IBB Position: Q3 2025 in Review

Counterweight Ventures sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 9,315 shares — an estimated $1.18M sold.

Counterweight Ventures first reported a position in IBB in Q4 2023 and held it in 7 quarters. The position peaked at $1.23M in Q3 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Counterweight Ventures reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Counterweight Ventures sold 9,315 iShares Biotechnology ETF shares in Q3 2025, an estimated $1.18M.
  • Counterweight Ventures first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 7 quarters.
  • Counterweight Ventures's iShares Biotechnology ETF position peaked at $1.23M in Q3 2024.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Counterweight Ventures's 13F filing for Q3 2025, filed 14 Nov 2025.